Cambridge Antibody - Directors' Shareholdings
22 December 1997 - 11:36PM
UK Regulatory
RNS No 9851k
CAMBRIDGE ANTIBODY TECHNOLOGY
22nd December 1997
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
John Aston
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT Group Employees' Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees' Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme
and a separate grant of options
7 Number of shares/amount of stock acquired:
227
8 Percentage of issued class:
9 Number of shares/amount of stock disposed:
10 Percentage of issued class:
0.001%
11 Class of security:
10p Ordinary Shares
12 Price per share:
375p
13 Date of transaction:
December 19 1997
14 Date company informed:
December 19 1997
15 Total holding following this notification:
1227
16 Total percentage holding of issued class following this notification:
0.006%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
December 19 1997
18 Period during which or date on which exercisable:
December 19 2000- December 19 2007
19 Total amount paid (if any) for grant of the option:
NIL
20 Description of shares or debentures involved: class, number:
10p Ordinary Shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
500p
22 Total number of shares or debentures over which options held following
this notification:
134000
23 Contact name for queries:
Diane Mellett
24 Contact telephone number:
01763 269245
25 Name of company official responsible for making notification:
Diane Mellett Company Secretary
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
David Chiswell
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
Cat Group Employees Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme
7 Number of shares/amount of stock acquired:
227
8 Percentage of issued class:
0.001%
9 Number of shares/amount of stock disposed:
10 Percentage of issued class:
11 Class of security:
10p Ordinary Shares
12 Price per share:
375p
13 Date of transaction:
19 December 1997
14 Date company informed:
19 December 1997
15 Total holding following this notification:
250227
16 Total percentage holding of issued class following this notification:
1.129%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
Diane Mellett
24 Contact telephone number:
01763 269 245
25 Name of company official responsible for making notification:
Diane Mellett Company Secretary
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
David Glover
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
Director
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT Group Employees Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees Trustees
Limited the Corporate Trustee of an an Inland Revenue approved Staff Share
Scheme and a separate grant of options
7 Number of shares/amount of stock acquired:
227
8 Percentage of issued class:
0.001%
9 Number of shares/amount of stock disposed:
10 Percentage of issued class:
11 Class of security:
10p Ordinary Shares
12 Price per share:
375p
13 Date of transaction:
December 19 1997
14 Date company informed:
December 19 1997
15 Total holding following this notification:
6427
16 Total percentage holding of issued class following this notification:
0.029%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
December 19 1997
18 Period during which or date on which exercisable:
December 19 2000- December 19 2007
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
10p Ordinary Shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
500p
22 Total number of shares or debentures over which options held following
this notification:
90,000
23 Contact name for queries:
Diane Mellett
24 Contact telephone number:
01763 269245
25 Name of company official responsible for making notification:
Diane Mellett Company Secretary
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Kevin Johnson
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
For Director
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
Cat Group Employees' Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of Shares on behalf of Director to Cat Group Employees' Trustees
Limited the Corporate Trustee of an Inland Revenue approved Staff Share Scheme
and a separate grant of options
7 Number of shares/amount of stock acquired:
227
8 Percentage of issued class:
0.001%
9 Number of shares/amount of stock disposed:
10 Percentage of issued class:
11 Class of security:
10p Ordinary Shares
12 Price per share:
375p
13 Date of transaction:
19 December 1997
14 Date company informed:
19 December 1997
15 Total holding following this notification:
227
16 Total percentage holding of issued class following this notification:
0.001%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
19 December 1997
18 Period during which or date on which exercisable:
19 December 2000- 19 December 2007
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
10p Ordinary Shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
500p
22 Total number of shares or debentures over which options held following
this notification:
152,500
23 Contact name for queries:
Diane Mellett
24 Contact telephone number:
01763 269 245
25 Name of company official responsible for making notification:
Diane Mellett Company Secretary
END
RDAOCBCBBDDDPBB
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2024 to Aug 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Aug 2023 to Aug 2024